Export 5 results:
Filters: Author is Kenneth Turteltaub and Type is Journal Article  [Clear All Filters]
2018
Hummel JM, Madeen E, Siddens LK, Uesugi S, McQuistan T, Anderson KA, Turteltaub K, Ognibene TJ, Bench G, Krueger SK et al..  2018.  Pharmacokinetics of [C]-Benzo[a]pyrene (BaP) in humans: Impact of Co-Administration of smoked salmon and BaP dietary restriction.. Food Chem Toxicol. 115:136-147.
2019
Madeen E, Siddens LK, Uesugi S, McQuistan T, Corley RA, Smith J, Waters KM, Tilton SC, Anderson KA, Ognibene TJ et al..  2019.  Toxicokinetics of benzo[a]pyrene in humans: Extensive metabolism as determined by UPLC-accelerator mass spectrometry following oral micro-dosing.. Toxicol Appl Pharmacol. 364:97-105.
2022
Monica L. Vermillion Maier, Siddens LK, Pennington J, Uesugi S, Anderson KA, Tidwell LG, Tilton SC, Ognibene TJ, Turteltaub K, Smith J et al..  2022.  Benzo[a]pyrene (BaP) metabolites predominant in human plasma following escalating oral micro-dosing with [C]-BaP.. Environ Int. 159:107045.
2023
Monica L. Vermillion Maier, Siddens LK, Pennington J, Uesugi S, Tilton SC, Vertel EA, Anderson KA, Tidwell LG, Ognibene TJ, Turteltaub K et al..  2023.  Benzo[a]pyrene toxicokinetics in humans following dietary supplementation with 3,3'-diindolylmethane (DIM) or Brussels sprouts.. Toxicol Appl Pharmacol. :116377.
Monica L. Vermillion Maier, Siddens LK, Pennington J, Uesugi S, Labut EM, Vertel EA, Anderson KA, Tidwell LG, Tilton SC, Ognibene TJ et al..  2023.  Impact of phenanthrene co-administration on the toxicokinetics of benzo[a]pyrene in humans. UPLC-accelerator mass spectrometry following oral microdosing.. Chem Biol Interact. 382:110608.